Apeloa Pharmaceutical (000739.SZ) has signed a strategic cooperation framework agreement with Jitai Technology.
Pro Pharma (000739.SZ) announced that the company recently signed a "Strategic Cooperation Framework Agreement" with Jitai Technology (Beijing) Co., Ltd. (referred to as "Jitai Technology"), establishing a strategic partnership to engage in long-term cooperation on CDMO and related projects. The agreement is valid for five years. The cooperation includes CDMO service collaboration, potential capital and industrial synergy cooperation, and joint development of improved new drugs.
Apeloa Pharmaceutical (000739.SZ) announced that it has recently signed a "Strategic Cooperation Framework Agreement" with JiTai Technology (Beijing) Co., Ltd. (referred to as "JiTai Technology"), forming a strategic partnership for long-term cooperation on CDMO and related projects. The agreement is valid for five years. The cooperation includes CDMO service collaboration, potential capital and industry synergy collaboration, and joint development of improved new drugs.
Related Articles
FUSEN PHARM (01652): Four products are expected to win bids in the national centralized drug procurement.
Shengda Resources (000603.SZ) subsidiary Honglin Mining has obtained the safety production license for the tailings pond.
EUROEYES (01846): Rens Laurentius Michal Schoenmakers has been appointed as Executive Director.
FUSEN PHARM (01652): Four products are expected to win bids in the national centralized drug procurement.
Shengda Resources (000603.SZ) subsidiary Honglin Mining has obtained the safety production license for the tailings pond.
EUROEYES (01846): Rens Laurentius Michal Schoenmakers has been appointed as Executive Director.
RECOMMEND
